Straumann Holding AGXSWX:STMN -1.89%100 Cash Ratio is 0.66 as of Dec. 2025, which is 22% below its 10-year median of 0.85. GuruFocus rates XSWX:STMN with a GF Score™ of 100/100 and a GF Value™ of CHF137.32 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 842 Medical Devices & Instruments companies, Straumann Holding AG ranks worse than 61.64% on this metric.
Straumann Holding AG has a Cash Ratio of 0.66. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Straumann Holding AG's Cash Ratio or its related term are showing as below:
XSWX:STMN'
s Cash Ratio Range Over the Past 10 Years
Min: 0.41 Med: 0.85 Max: 1.67
Current: 0.66
During the past 13 years, Straumann Holding AG's highest Cash Ratio was 1.67. The lowest was 0.41. And the median was 0.85.
XSWX:STMN's Cash Ratio is ranked worse than 61.64% of 842
companies
in the Medical Devices & Instruments industry
Industry Median: 0.97
vs XSWX:STMN: 0.66
Straumann Holding AG (XSWX:STMN) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Straumann Holding AG Cash Ratio Related Terms
Straumann Holding AG Cash Ratio Historical Data
* Premium members only.
The historical data trend for Straumann Holding AG's Cash Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:STMN vs ISRG, BDX, MDLN: Cash Ratio Comparison
For the Medical Instruments & Supplies subindustry, Straumann Holding AG's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Straumann Holding AG Cash Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Straumann Holding AG's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Straumann Holding AG (XSWX:STMN) has a Cash Ratio of 0.66 as of Dec. 2025. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Straumann Holding AG and its competitors. This is 22% below median its historical median of 0.85. Over the past decade, Straumann Holding AG's Cash Ratio has ranged from 0.41 to 1.67. According to the industry distribution chart, Straumann Holding AG ranks #519 out of 842 companies in the Medical Devices & Instruments industry, placing it in the top 61.6%.
Is Straumann Holding AG's Cash Ratio too high?
Straumann Holding AG's current Cash Ratio of 0.66 is 22% below median its 10-year median of 0.85. Over the past 10 years, this metric has ranged from a low of 0.41 to a high of 1.67. The Medical Devices & Instruments industry median Cash Ratio is 0.97. Straumann Holding AG's value of 0.66 is 32% below this industry median. Based on the distribution chart, Straumann Holding AG ranks #519 out of 842 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Straumann Holding AG has a GF Score™ of 100/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Straumann Holding AG's Cash Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Straumann Holding AG ranks #519 out of 842 companies for Cash Ratio. This places Straumann Holding AG in the lower half of its industry. The industry median Cash Ratio is 0.97. Straumann Holding AG's value of 0.66 is 32% below this benchmark. Historically, Straumann Holding AG's own Cash Ratio has ranged from 0.41 to 1.67 over the past decade. While the company's 10-year median is 0.85 vs. the industry median of 0.97, Straumann Holding AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Devices & Instruments company?
The median Cash Ratio among Medical Devices & Instruments companies is 0.97, based on 842 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Straumann Holding AG's current Cash Ratio of 0.66 is 32% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Straumann Holding AG and its competitors. For the Medical Devices & Instruments industry, the median Cash Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Straumann Holding AG's current Cash Ratio is 0.66, which is 22% below median its own 10-year median of 0.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Straumann Holding AG stock overvalued right now?
Based on GuruFocus' analysis, Straumann Holding AG (XSWX:STMN) is currently considered Modestly Undervalued. The stock's GF Value™ is CHF137.32, compared to a current price of CHF106.30 — trading 22.6% below its estimated fair value. The current Cash Ratio is 0.66, which is 22% below median its 10-year median of 0.85 and 32% below the Medical Devices & Instruments industry median of 0.97. Straumann Holding AG's overall GF Score™ is 100/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Straumann Holding AG (XSWX:STMN), the current Cash Ratio is 0.66 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Straumann Holding AG (XSWX:STMN) Overvalued in 2026?
Based on GuruFocus' analysis, Straumann Holding AG stock appears to be undervalued.
The current stock price of CHF106.30 is trading 22.6% below its estimated GF Value™ of CHF137.32.
GuruFocus considers Straumann Holding AG to be Modestly Undervalued.
Key valuation signals for XSWX:STMN:
Cash Ratio: 0.66 (22% below median its 10-year median of 0.85)
GF Value™: CHF137.32 vs. price of CHF106.30 (22.6% below fair value)
Industry Position: 32% below the Medical Devices & Instruments median (#519 of 842)
No single metric tells the full story. See the XSWX:STMN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The firm's core products are dental implants, and it holds over one third of the CHF 6 billion global market. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.
100GF Score
Get the complete analysis for XSWX:STMN
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:STMN has been successfully added to your 
